Rankings
▼
Calendar
PRAX Q1 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$431,000
-36.9% YoY
Gross Profit
-$27M
-6160.8% margin
Operating Income
-$42M
-9718.3% margin
Net Income
-$40M
-9177.0% margin
EPS (Diluted)
$-2.84
QoQ Revenue Growth
-16.3%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$250M
Total Liabilities
$21M
Stockholders' Equity
$230M
Cash & Equivalents
$152M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$431,000
$683,000
-36.9%
Gross Profit
-$27M
-$25M
-7.0%
Operating Income
-$42M
-$38M
-10.0%
Net Income
-$40M
-$37M
-5.6%
Revenue Segments
License
$400,000
100%
← FY 2024
All Quarters
Q2 2024 →